Subject Areas : Report of Health Care

Amir Hajighasem ¹ , parvin farzanegi ² , Zohreh Mazaheri ³

1 - Department of Exercise Physiology, Sari Branch, Islamic Azad University, Sari, Iran
2 - Department of Exercise Physiology, Sari Branch, Islamic Azad University, Sari, Iran
3 - Department of Anatomical Sciences, Tarbiat Modares University, Tehran, Iran

Received: 2018-09-03 Accepted : 2018-09-03 Published : 2018-10-01

Keywords:

References:

1. Hardy T, McPherson S, Editorial: NAFLD in Asia-clinical associations with advanced disease become clearer. Aliment Pharmacol Ther. 2018; 47 (7): 1035- 1036.


2. Henao- Mejia J, Elinav E, Jin C, Hao L, Mehal WZ, Strowig T, et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature, 2012; 482 (7384): 179- 185.


3. Inoue H, Kishimoto A, Ushikoshi-Nakayama R, Hasaka A, Takahashi A, Ryo K, et al. Resveratrol improves salivary dysfunction in a non-obese diabetic (NOD) mouse model of Sjogren's syndrome. J Clin Biochem Nutr. 2016; 59 (2): 107- 112.


4. Park HG, Lee YR, Jun JK , Lee WL. Exercise training is more effective than resveratrol supplementation on alleviation of inflammation in peritoneal macrophages of high fat diet mice. J Exerc Nutrition Biochem. 2014; 18 (1): 79- 87.


5. Shojaee- Moradie F, Cuthbertson DJ, Barrett M, Jackson NC, Herring R, Thomas EL, et al. Exercise training reduces liver fat and increases rates of VLDL clearance but not VLDL production in NAFLD. J Clin Endocrinol Metab. 2016; 101 (11): 4219- 4228.


6. Lanzilli G, Cottarelli A, Nicotera G, Guida S, Ravagnan G , Fuggetta MP. Anti-inflammatory effect of resveratrol and polydatin by in vitro IL-17 modulation. Inflammation. 2012; 35 (1): 240- 248.


7. Wenbin Z , Guojun G. Resveratrol ameliorates diabetes- induced renal damage through regulating the expression of TGF- beta1, collagen IV and Th17/Treg-related cytokines in rats. West Indian Med J. 2014; 63 (1): 20- 25.


8. Voduc N, la Porte C, Tessier C, Mallick R, Cameron DW. Effect of resveratrol on exercise capacity: a randomized placebo-controlled crossover pilot study. Appl Physiol Nutr Metab. 2014; 39 (10): 1183- 1187.


9. Batacan RB, Duncan MJ, Dalbo VJ, Connolly KJ, Fenning AS. Light-intensity and high-intensity interval training improve cardiometabolic health in rats. Appl Physiol Nutr Metab. 2016; 41 (9): 945- 952.


10. Freitas DA, Rocha-Vieira E, Soares BA, Nonato LF, Fonseca SR, Martins JB, et al. High intensity interval training modulates hippocampal oxidative stress, BDNF and inflammatory mediators in rats. Physiol Behav. 2017; 184: 6- 11.


11. Hajighasem A, Farzanegi P, Mazaheri Z. Effects of combined therapy with resveratrol, continuous and interval exercises on apoptosis, oxidative stress, and inflammatory biomarkers in the liver of old rats with non-alcoholic fatty liver disease. Arch Physiol Biochem. 2018; 20: 1- 8.


12. Almeida OF, Conde GL, Crochemore C, Demeneix BA, Fischer D, Hassan AH, et al. Subtle shifts in the ratio between pro- and antiapoptotic molecules after activation of corticosteroid receptors decide neuronal fate. FASEB J. 2000; 14 (5): 779- 790.


13. Pollack M, Phaneuf S, Dirks A , Leeuwenburgh C. The role of apoptosis in the normal aging brain, skeletal muscle, and heart. Ann N Y Acad Sci. 2002; 959: 93- 107.


14. Luukkonen PK, Zhou Y, Nidhina Haridas PA, Dwivedi OP, Hyotylainen T, Ali A, et al. Impaired hepatic lipid synthesis from polyunsaturated fatty acids in TM6SF2 E167K variant carriers with NAFLD. J Hepatol. 2017; 67 (1): 128- 136.


15. Ichino N, Osakabe K, Sugimoto K, Suzuki K, Yamada H, Takai H, et al. The NAFLD index: A simple and accurate screening tool for the prediction of non- alcoholic fatty liver disease. Rinsho Byori. 2015; 63 (1): 32- 43.


16. Kumar A, Sharma A, Duseja A, Das A, Dhiman RK, Chawla YK, et al. Patients with nonalcoholic fatty liver disease (NAFLD) have higher oxidative stress in comparison to chronic viral hepatitis. J Clin Exp Hepatol. 2013; 3 (1): 8- 12.


17. El-Din SH, Sabra AN, Hammam OA, Ebeid FA, El-Lakkany NM. Pharmacological and antioxidant actions of garlic and.or onion in non-alcoholic fatty liver disease (NAFLD) in rats. J Egypt Soc Parasitol. 2014; 44 (2): 295- 308.


18. Ding C, Zhao Y, Shi X, Zhang N, Zu G, Li Z, et al. New insights into salvianolic acid A action: Regulation of the TXNIP/NLRP3 and TXNIP/ChREBP pathways ameliorates HFD-induced NAFLD in rats. Sci Rep. 2016; 6: 28734.


19. Wang H, Jiang T, Li W, Gao N, Zhang T. Resveratrol attenuates oxidative damage through activating mitophagy in an in vitro model of Alzheimer's disease. Toxicol Lett. 2018; 282: 100- 108.


20. Palacz-Wrobel M, Borkowska P, Paul-Samojedny M, Kowalczyk M, Fila-Danilow A, Suchanek-Raif R, et al. Effect of apigenin, kaempferol and resveratrol on the gene expression and protein secretion of tumor necrosis factor alpha (TNF-alpha) and interleukin-10 (IL-10) in RAW-264.7 macrophages. Biomed Pharmacother. 2017; 93: 1205- 1212.


21. Zheng Y, Zhao Z, Wu W, Song C, Meng S, Fan L, et al. Effects of dietary resveratrol supplementation on hepatic and serum pro-/anti-inflammatory activity in juvenile GIFT tilapia, Oreochromis niloticus. Dev Comp Immunol. 2017; 73: 220- 228.


22. Wang D, Li SP, Fu JS, Bai L , Guo L. Resveratrol augments therapeutic efficiency of mouse bone marrow mesenchymal stem cell-based therapy in experimental autoimmune encephalomyelitis. Int J Dev Neurosci. 2016; 49: 60- 66.


23. Chen Q, Wang T, Li J, Wang S, Qiu F, Yu H, et al. Effects of natural products on fructose-induced nonalcoholic fatty liver disease (NAFLD). Nutrients. 2017; 9 (2): E96.


24. Wang ZM, Chen YC, Wang DP. Resveratrol, a natural antioxidant, protects monosodium iodoacetate-induced osteoarthritic pain in rats. Biomed Pharmacother. 2016; 83: 763- 770.


25. Sun S, Zhang M, Yang Q, Shen Z, Chen J, Yu B, et al. Resveratrol suppresses lipoprotein-associated phospholipase A2 expression by reducing oxidative stress in macrophages and animal models. Mol Nutr Food Res. 2017; 61 (10): 1601112.


26. Elbe H, Gul M, Cetin A, Taslidere E, Ozyalin F, Turkoz Y, et al. Resveratrol reduces light and electron microscopic changes in acetaminophen-induced hepatotoxicity in rats: Role of iNOS expression. Ultrastruct Pathol. 2017; 1- 10.


27. Faghihzadeh F, Adibi P, Rafiei R , Hekmatdoost A. Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease. Nutr Res. 2014; 34 (10): 837- 843.


28. Tung BT, Rodriguez-Bies E, Talero E, Gamero-Estevez E, Motilva V, Navas P, et al. Anti-inflammatory effect of resveratrol in old mice liver. Exp Gerontol. 2015; 64: 1- 7.


29. Jeong JH, Lee YR, Park HG , Lee WL. The effects of either resveratrol or exercise on macrophage infiltration and switching from M1 to M2 in high fat diet mice. J Exerc Nutrition Biochem. 2015; 19 (2): 65- 72.


30. Tung BT, Rodriguez-Bies E, Ballesteros-Simarro M, Motilva V, Navas P , Lopez-Lluch G. Modulation of endogenous antioxidant activity by resveratrol and exercise in mouse liver is age dependent. J Gerontol A Biol Sci Med Sci. 2014; 69 (4): 398- 409.